OA03630A - Process for the preparation of a new family of compounds with antispasmodic, antiarrhythmic, antipyretic and antimalarial activity. - Google Patents
Process for the preparation of a new family of compounds with antispasmodic, antiarrhythmic, antipyretic and antimalarial activity.Info
- Publication number
- OA03630A OA03630A OA53676A OA53676A OA03630A OA 03630 A OA03630 A OA 03630A OA 53676 A OA53676 A OA 53676A OA 53676 A OA53676 A OA 53676A OA 03630 A OA03630 A OA 03630A
- Authority
- OA
- OAPI
- Prior art keywords
- antispasmodic
- antiarrhythmic
- antipyretic
- compounds
- preparation
- Prior art date
Links
- 230000003288 anthiarrhythmic effect Effects 0.000 title 1
- 230000000078 anti-malarial effect Effects 0.000 title 1
- 230000001754 anti-pyretic effect Effects 0.000 title 1
- 230000002921 anti-spasmodic effect Effects 0.000 title 1
- 239000003416 antiarrhythmic agent Substances 0.000 title 1
- 239000002221 antipyretic Substances 0.000 title 1
- 239000000812 cholinergic antagonist Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- C07D453/04—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3438268 | 1968-07-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA03630A true OA03630A (en) | 1971-12-24 |
Family
ID=10364956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA53676A OA03630A (en) | 1968-07-18 | 1969-07-18 | Process for the preparation of a new family of compounds with antispasmodic, antiarrhythmic, antipyretic and antimalarial activity. |
Country Status (8)
| Country | Link |
|---|---|
| BE (1) | BE735129A (en) |
| CH (1) | CH502386A (en) |
| DE (1) | DE1936723C2 (en) |
| ES (1) | ES369337A1 (en) |
| FR (1) | FR2013170A1 (en) |
| GB (1) | GB1227830A (en) |
| NL (1) | NL149808B (en) |
| OA (1) | OA03630A (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1294538A (en) * | 1970-04-30 | 1972-11-01 | Rech S Et D Applic Scient Soge | Pharmaceutical compositions |
| FR2201898A1 (en) * | 1973-05-30 | 1974-05-03 | Sogeras | Vincamine arabogalactan sulphate - with prolonged activity for treating cerebrovascular disorders |
| US6077822A (en) * | 1993-09-14 | 2000-06-20 | Dumex-Alpharma A/S | Drug salts |
| CA2148607A1 (en) * | 1993-09-20 | 1995-03-30 | Ivan Havlik | Antimalarial drug |
| ATE171456T1 (en) * | 1994-06-10 | 1998-10-15 | Dumex Ltd As | SALTS OF MEDICATIONS |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1143204B (en) * | 1958-08-05 | 1963-02-07 | Mundipharma Ag | Process for the preparation of quinidine galacturonate and quinidine polygalacturonate |
| DE1218457B (en) * | 1961-10-10 | 1966-06-08 | Mundipharma Ag | Process for the preparation of dihydroquinidine galacturonate and dihydroquinidine polygalacturonate |
-
1968
- 1968-07-18 GB GB3438268A patent/GB1227830A/en not_active Expired
-
1969
- 1969-06-25 BE BE735129D patent/BE735129A/xx not_active IP Right Cessation
- 1969-06-26 CH CH994669A patent/CH502386A/en not_active IP Right Cessation
- 1969-07-09 ES ES369337A patent/ES369337A1/en not_active Expired
- 1969-07-10 FR FR6923466A patent/FR2013170A1/fr active Pending
- 1969-07-17 NL NL696910987A patent/NL149808B/en not_active IP Right Cessation
- 1969-07-18 DE DE1936723A patent/DE1936723C2/en not_active Expired
- 1969-07-18 OA OA53676A patent/OA03630A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR2013170A1 (en) | 1970-03-27 |
| DE1936723A1 (en) | 1970-05-14 |
| ES369337A1 (en) | 1971-06-01 |
| NL149808B (en) | 1976-06-15 |
| NL6910987A (en) | 1970-01-20 |
| BE735129A (en) | 1969-12-01 |
| GB1227830A (en) | 1971-04-07 |
| DE1936723C2 (en) | 1983-12-22 |
| CH502386A (en) | 1971-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| OA03859A (en) | Process for the production of compounds with pharmaceutical activity. | |
| FR2317912A1 (en) | NEW PHARMACEUTICAL COMPOSITION FOR PARENTERAL ADMINISTRATION, ACTING ON THE CENTRAL NERVOUS SYSTEM | |
| CH537978A (en) | Process for preparing a beer wort, and wort resulting from the process | |
| OA04093A (en) | Process for the preparation of ortho-disubstituted aryl-guanidines. | |
| OA03630A (en) | Process for the preparation of a new family of compounds with antispasmodic, antiarrhythmic, antipyretic and antimalarial activity. | |
| FR1448790A (en) | Process for the preparation of alpha-monochloro-nu, nu-dialkoyl-aceto-acetamides | |
| OA03864A (en) | Process for the preparation of a medicament based on pyridoxine P-chlophenoxyisobutyrate. | |
| FR1504480A (en) | Improvement relating to a process for the preparation of 1, 2-dichloroethane | |
| FR1533178A (en) | Process for the preparation of crosslinked synthetic resins based on polyhydroxy compounds, polyisocyanates and chain extenders | |
| CH448990A (en) | Process for the preparation of a new monocarbamate of a propane 1,3-diol | |
| CH556327A (en) | PROCESS FOR THE PREPARATION OF A DECAPEPTIDE. | |
| CH525854A (en) | Process for the preparation of a p-nitrophenol | |
| OA00939A (en) | Process for the preparation of amino-isoxazoles. | |
| OA04265A (en) | Process for obtaining uranium compounds. | |
| SE384863B (en) | PROCEDURE FOR THE PREPARATION OF 3,6-BIS- (2- (1-AZABICYCLO (3,1,0) -HEXANE)) - 2,5-PIPERAZINDION | |
| FR2274337A1 (en) | LINING ELEMENTS, ESPECIALLY FOR DISTILLATION AND ABSORPTION COLUMNS | |
| OA04266A (en) | Process and device for the preparation of carbonaceous pastes intended for the manufacture of electrodes. | |
| BE658650A (en) | Process for the preparation of condensation products from diphenolic compounds and epihalogenhydrins. | |
| CH553738A (en) | PROCESS FOR THE PREPARATION OF A DIALCOYLACETAL DU (BETA), (DELTA) -DIOXOENANTHALDEHYDE. | |
| FR1373390A (en) | Tedding machine, specially designed for forming swaths | |
| CH500994A (en) | Process for the preparation of compounds with antihistamine activity | |
| NO136195C (en) | PROCEDURES FOR THE PREPARATION OF 2,4-DIAMINO-5-BENZYLPYRIMIDINES. | |
| DK130967B (en) | Analogous process for the preparation of 2- (3,4-dichloroaniline) -quinolizine bromide. | |
| BE792330A (en) | PROCEDURE FOR PREVENTING RESINS FROM ADHESING TO A | |
| CH457111A (en) | Process for the preparation of a condiment |